iiinova — where your digital self keeps evolving

Ruesch Center @rueschcenter.bsky.social · 27/06/2025

Join us tomorrow morning, Friday, June 27th, from 9:00- 10:30 am, to review research from the #ASCO25 Annual Meeting. We will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers via Zoom. Register now: bit.ly/4k63Swd to receive the link.

010

Ruesch Center @rueschcenter.bsky.social · 12/06/2025

"Badge-up" with @marshalj23.bsky.social of @georgetownlombardi.bsky.social as he discusses #ASCO25 with @clinicalcaresol.bsky.social. Watch now: clinicalcaresolutions.net/activities/o...

033

Ruesch Center @rueschcenter.bsky.social · 11/06/2025

The Hidden Barriers Holding Back Cancer's Most Promising Treatments: Samir N. Khleif, MD of @georgetownlombardi.bsky.social shares his thoughts on the pace of innovation in immune checkpoint inhibitors. time.com/7292783/canc...

time.com

The Hidden Barriers Holding Back Promising Cancer Treatments

A perfect storm of scientific, economic, and cultural barriers are holding back immunotherapy's true potential, writes Samir Khleif.

010

Ruesch Center @rueschcenter.bsky.social · 11/06/2025

EGFR Inhibitors in the Treatment of Stage IV CRC: Benjamin Weinberg, MD, discusses with @medscape.com Hematology and Oncology Decision Point. decisionpoint.medscape.com/oncology/vie...

decisionpoint.medscape.com

EGFR Inhibitors in the Treatment of Stage IV CRC

Benjamin A. Weinberg, MD discusses EGFR inhibitors in the treatment of stage IV CRC.

000

Ruesch Center @rueschcenter.bsky.social · 06/06/2025

Join @medstarhealth.bsky.social for the 2025 Esophageal Symposium. Attendees will gain insights into identifying the pathophysiology associated with esophageal conditions, as well as guidance on testing, indications for therapy, and available endoscopic and surgical treatments. bit.ly/3FHX6On

000

Ruesch Center @rueschcenter.bsky.social · 03/06/2025

After #ASCO25, stay up-to-date on the latest GI Cancer Research. View this week's tailored GI Cancer publication output via bit.ly/454GquF and sign up to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

021

Ruesch Center @rueschcenter.bsky.social · 03/06/2025

Join us to review exciting research from the #ASCO25 Annual Meeting. Drs. Marshall, Weinberg, Noel, and Mukherji will highlight the most compelling abstracts in Colorectal, Pancreatic, Liver, and Upper GI cancers on June 27th via Zoom. Register today: bit.ly/4k63Swd @georgetownlombardi.bsky.social.

010

Ruesch Center @rueschcenter.bsky.social · 20/05/2025

Today, on Clinical Trials Day, we recognize and celebrate the contributions of clinical research professionals in advancing research at Lombardi Comprehensive Cancer Center. The Lombardi Clinical Trials Office provides administrative, nursing, and data management support for clinical trials.

000

Ruesch Center @rueschcenter.bsky.social · 19/05/2025

Register today for the 10th Annual GI Cancer Patient Summit on Saturday, July 12, 2025, from 10:00 am- 1:00 pm EST. The summit provides information and tools to manage cancer care. This free event is a partnership with Hope Connections for Cancer Support. bit.ly/GISummit25

000

Ruesch Center @rueschcenter.bsky.social · 16/05/2025

Learn more about BellRinger today! Join Team Ruesch as a rider, volunteer, or supporter as we gear up for BellRinger on October 24-25, 2025. 100% of funds raised from BellRinger support cancer research at @georgetownlombardi.bsky.social. bit.ly/RueschBellRinger

bit.ly

BellRinger | Team Ruesch

Support me as I fundraise for cancer research at Georgetown Lombardi Comprehensive Cancer Center

000

Ruesch Center @rueschcenter.bsky.social · 16/05/2025

This week, we highlighted research by Emil Lou (@cancerassassin1.bsky.social), Modassir S Choudhry, Timothy K Starr, Timothy D Folsom, Jason Bell, Blaine Rathmann, Anthony P DeFeo, Jihyun Kim, Branden S Moriarity, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3Fkx2bI.

021

Ruesch Center @rueschcenter.bsky.social · 15/05/2025

In this week's Ruesch Center GI Cancers publication search, @marshalj23.bsky.social highlighted research by Julien Taieb, Pierre Laurent-Puig, and others published in the Journal of Clinical Oncology. bit.ly/3Fkx2bI. Learn more: youtu.be/JlqL1f6vyak?...

youtu.be

Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer.

YouTube video by The Ruesch Center

011

Ruesch Center @rueschcenter.bsky.social · 09/05/2025

On Thursday, May 15th, join thousands of commuters in the DMV for Bike to Work Day! BellRinger will host its own stop at Georgetown Waterfront Park. Stop by to learn how to gear up to support critical research at @georgetownlombardi.bsky.social . Register today: bit.ly/4k5BABC.

020

Ruesch Center @rueschcenter.bsky.social · 08/05/2025

View this week's tailored GI Cancer publication output via bit.ly/431rg6J. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research excited you this week?

011

Ruesch Center @rueschcenter.bsky.social · 06/05/2025

Join Smith Center for the Healing and the Arts, Hope Connections for Cancer Support Community, Washington, D.C., and Cancer Choices for this virtual event on Wednesday, May 21st. Learn more and register today: smithcenter.org/programs-ret...

010

Ruesch Center @rueschcenter.bsky.social · 30/04/2025

This week, we highlighted research by Jill P Smith, Narayan Shivapurkar, Wenqiang Chen, Godhanjali Chekuri, Amani Dabney, Kyle Holmes, Hong Cao, Ruvanthi N Kularatne, and Stephan T Stern published in the Journal of Molecular Cancer Therapeutics. Learn more: bit.ly/4lTknwY

011

Ruesch Center @rueschcenter.bsky.social · 23/04/2025

Pancreatic Cancer 2025: After More Than 30 Years, Is That Light on the Horizon? @marshalj23.bsky.social shares insights in the Spring Issue of Oncolytics Today. Read the full article, pages 77-79-https://www.ncoda.org/news/oncolytics-today-spring-2025/

022

Ruesch Center @rueschcenter.bsky.social · 23/04/2025

This week, we highlighted exciting research by Berend J van der Wilk, Ben M Eyck, Bas P L Wijnhoven, Sjoerd M Lagarde, J Jan B van Lanschot, and others published in @thelancetoncol.bsky.social. Learn more: bit.ly/3GkX52V.

021

Ruesch Center @rueschcenter.bsky.social · 14/04/2025

Nominations are open for the 2025 Luminary Awards in GI Cancers! Submit your colleagues who have transformed the lives of GI cancer patients. Categories include MedOnc, Pre-clinical, Nursing, Surgery, and Advocacy. Awards will be presented on November 20th in D.C. bit.ly/LuminaryNomination

000

Ruesch Center @rueschcenter.bsky.social · 11/04/2025

This week, we highlighted research by Zhihao Lu, Wenting Du, Xi Jiao, Lin Shen, and others published in the Journal of Clinical Oncology. Learn more: bit.ly/43KNnAs.

010

Ruesch Center @rueschcenter.bsky.social · 10/04/2025

Targeted Therapy Options Sometimes Underutilized in Metastatic CRC. @marshalj23.bsky.social, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer. www.targetedonc.com/view/targete...

targetedonc.com

Targeted Therapy Options Sometimes Underutilized in Metastatic CRC

John L. Marshall, MD, discusses the sequencing of targeted therapy for refractory metastatic colorectal cancer.

011

Ruesch Center @rueschcenter.bsky.social · 08/04/2025

Mass layoffs. Funding cuts. Uncertain futures. @marshalj23.bsky.social unpacks the turmoil hitting federal health agencies and what it means for researchers, clinical trials, and patient care. Who benefits from this chaos, and how can the medical community push back? bit.ly/42nXXLw

clinicalcaresolutions.net

Episode 13 | CCS

As a nationally recognized provider of continuing education for healthcare professionals, CCS develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.

011

Ruesch Center @rueschcenter.bsky.social · 08/04/2025

'Scientists at the National Institutes of Health demonstrated a promising step toward using a person's immune cells to fight gastrointestinal cancers in a paper in Nature Medicine on Tuesday, the same day the agency was hit with devastating layoffs that left many NIH personnel in tears.'

washingtonpost.com

NIH scientists have a cancer breakthrough. Layoffs are delaying it.

A big step forward in cancer therapy has been slowed by layoffs and new restrictions at the National Institutes of Health, where it was developed.

010

Ruesch Center @rueschcenter.bsky.social · 07/04/2025

View this week's tailored GI Cancer publication output via bit.ly/4hoxqmx. Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub. What research did you find most compelling this week?

010

Ruesch Center @rueschcenter.bsky.social · 07/04/2025

marshalj23.bsky.social and marklewismd.bsky.social discuss how BESPOKE trial results demonstrate significantly improved disease-free survival rates in patients with negative circulating tumor DNA (ctDNA) status compared with those with detectable ctDNA. bit.ly/420Ysfw

bit.ly

BESPOKE: Highlighting the Disease-Free Survival by ctDNA Status

Panelists discuss how BESPOKE trial results demonstrate significantly improved disease-free survival rates in patients with negative circulating tumor DNA (ctDNA) status compared with those with detec...

000

Ruesch Center @rueschcenter.bsky.social · 07/04/2025

Congratulations to Harry Sun (C’26) on being named a 2025 Goldwater Scholar. Sun researches immunology in Dr. Anton Wellstein’s lab @georgetownlombardi.bsky.social, where he has contributed to projects such as liquid biopsy analysis in cancer patients. georgetown.edu/news/junior-...

georgetown.edu

Junior Receives 2025 Goldwater Scholarship for Cancer Research - Georgetown University

Harry Sun, a biology major, was named a Goldwater Scholar, a national award for the next generation of scientists, researchers and engineers.

000

Ruesch Center @rueschcenter.bsky.social · 07/04/2025

.@marshalj23.bsky.social and @marklewismd.bsky.social discuss the BESPOKE trial enrolled a diverse cohort of patients with varying demographic profiles, disease stages, comorbidities, and treatment histories to ensure comprehensive representation for personalized medicine approaches. bit.ly/4jf1O44

cancernetwork.com

Overview of BESPOKE Patient Characteristics

Panelists discuss how the BESPOKE trial enrolled a diverse cohort of patients with varying demographic profiles, disease stages, comorbidities, and treatment histories to ensure comprehensive represen...

000

Ruesch Center @rueschcenter.bsky.social · 07/04/2025

Ruesch is gearing up for BellRinger on October 24-25th. This event supports crucial oncology research at @georgetownlombardi.bsky.social. Join us as a rider, volunteer, or supporter and be part of our mission to end cancer. Together, we can make a significant ride.bellringer.org/team/teamrue...

000

Ruesch Center @rueschcenter.bsky.social · 26/03/2025

“Early detection makes this one of the most preventable and treatable cancers,” said Dr. Marcus Noel, medical oncologist at MedStar Georgetown University Hospital and Associate Professor of Medicine in the Department of Medicine at Georgetown University. afro.com/colon-cancer...

afro.com

To be young, gifted and…healthy: The new face of colon cancer survivors

National Colon Cancer Awareness Month highlights the higher incidence of colon cancer in Black communities and the importance of early detection and treatment.

000

Ruesch Center @rueschcenter.bsky.social · 23/03/2025

The Ruesch team was thrilled to participate in this year’s #ScopeItOut and to support the work of the Colorectal Cancer Alliance in raising awareness about #ColorectalCancer.

011

Ruesch Center @rueschcenter.bsky.social · 19/03/2025

This morning, the Ruesch Center shared resources for #ColorectalAwarenessMonth at @georgetownlombardi.bsky.social. Learn more about the activities we’re engaging in with our partners to raise awareness about colorectal cancer and support the CRC community. ruesch.georgetown.edu/partnerevents/

020

Ruesch Center @rueschcenter.bsky.social · 18/03/2025

On Sunday, March 23rd, we are excited to participate in this year’s ScopeItOut and to support the work of the Colorectal Cancer Alliance in raising awareness about #ColorectalCancer. Join the Ruesch team today! bit.ly/3DZzXG9.

031

Ruesch Center @rueschcenter.bsky.social · 12/03/2025

View this week's tailored GI Cancer publication output via bit.ly/4hoxqmx. What research was particularly interesting to you this week? Sign up today to have this weekly list delivered to your inbox: bit.ly/RueschWeeklyPub.

011

Ruesch Center @rueschcenter.bsky.social · 11/03/2025

We were excited to join @fightcrc.bsky.social on the National Mall this evening to raise awareness about colorectal cancer at the United in Blue Rally. @georgetownlombardi.bsky.social #ColorectalCancerAwarenessMonth.

021

Reposted by Ruesch Center

Fight Colorectal Cancer @fightcrc.bsky.social · 09/03/2025

Can’t make it to D.C.? No worries – you can still advocate with us! Our easy-to-use action alerts take less than a minute to complete. 💪 #PrioritizeCRC fightcolorectalcancer.org/take-action/

051

Ruesch Center @rueschcenter.bsky.social · 07/03/2025

Today is Dress in Blue Day! The Clinical Research Management Office and Ruesch Center faculty @georgetownlombardi.bsky.social wear blue to raise awareness of colorectal cancer and support the CRC community. #ColorectalCancerAwarenessMonth #DressInBlueDay @medstarhealth.bsky.social

031

Ruesch Center @rueschcenter.bsky.social · 06/03/2025

The Ruesch Center is proud to support the Colorectal Cancer Alliance at this year's #ScopeItOut on Sunday, March 23, 2025. Learn more about this exciting event and join our team! Registration is free for patients and survivors. impact.ccalliance.org/team/641103

021